Author

Davide Ronchi

Observed name: D. Ronchi

Institution: Aptuit (Italy)

Observed institutions: University of Pavia, Aptuit (Italy)

ORCID: 0009-0004-5964-6356

Observed ORCID: 0009-0004-5964-6356

OpenAlex ID: A5014032995

Replacement, Reduction, and Refinement of Animal Experiments in Anticancer Drug Development: The Contribution of 3D In Vitro Cancer Models in the Drug Efficacy Assessment

2023 · Elena M. Tosca, Davide Ronchi, et al. · Biomedicines · 96

Model‐Informed Reinforcement Learning for Enabling Precision Dosing Via Adaptive Dosing

2024 · Elena Maria Tosca, Alessandro De Carlo, et al. · Clinical Pharmacology & Therapeutics · 52

Predicting ADMET Properties from Molecule SMILE: A Bottom-Up Approach Using Attention-Based Graph Neural Networks

2024 · Alessandro De Carlo, Davide Ronchi, et al. · Pharmaceutics · 40

Predicting Tumor Volume Doubling Time and Progression-Free Survival in Untreated Patients from Patient-Derived-Xenograft (PDX) Models: A Translational Model-Based Approach

2024 · E. M. Tosca, D. Ronchi, et al. · The AAPS Journal · 7

From lichen to organoids: Usnic acid enantiomers show promise against Cholangiocarcinoma via MNK2 targeting and MAPK pathway modulation

2025 · Valeria Cavalloro, Alessio Malacrida, et al. · Biomedicine & Pharmacotherapy · 6

Predicting tumor dynamics in treated patients from patient-derived-xenograft mouse models: a translational model-based approach

2025 · D. Ronchi, E. M. Tosca, et al. · Journal of Pharmacokinetics and Pharmacodynamics · 3

Intrahepatic cholangiocarcinoma-derived organoids for disease modelling and drug screening

2024 · S. De Siervi, S. Conti Nibali, et al. · Digestive and Liver Disease · 1

Patient-derived liver organoids as an in vitro model to study new personalized therapies targeting VDAC1 in intrahepatic cholangiocarcinoma

2023 · S. De Siervi, S. Conti Nibali, et al. · Digestive and Liver Disease · 1

Impact of GPR39 Inhibition on Tissue Oxygen Tension in Acute Myocardial Infarction: Modeling Using an Indirect Response Pharmacokinetics/Pharmacodynamics Approach

2026 · Davide Ronchi, Chiara Roversi, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Development of new personalized therapies targeting VDAC1 in intrahepatic cholangiocarcinoma using patient-derived liver organoids

2023 · Silvia De Siervi, Stefano Conti Nibali, et al. · Journal of Hepatology

Works count: 10

Citation count: 206

H-index: 5

I10-index: 3